BVNXF (Bioventix) ROCE %: 82.90% (As of Dec. 2025)


BVNXF Bioventix PLC BVNXF
62 GF Score
Price $14.71
GF Value $32.94
! 3 Warning Signs
View Full Analysis

What is Bioventix ROCE %?

Bioventix BVNXF 62 ROCE % is 82.90% as of Dec. 2025. GuruFocus rates BVNXF with a GF Score™ of 62/100 and a GF Value™ of $32.94. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bioventix's annualized ROCE % for the quarter that ended in Dec. 2025 was 82.90%.

Bioventix  (OTCPK:BVNXF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bioventix ROCE % Related Terms

Bioventix ROCE % Historical Data

* Premium members only.

The historical data trend for Bioventix's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioventix ROCE % Chart

Bioventix Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.24 73.01 85.14 88.57 88.34

Bioventix Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.83 93.50 85.88 91.72 82.90
BVNXF
62GF Score
Bioventix PLC BVNXF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioventix ROCE % Calculation

Bioventix's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=13.669/( ( (17.469 - 2.198) + (17.455 - 1.78) )/ 2 )
=13.669/( (15.271+15.675)/ 2 )
=13.669/15.473
=88.34 %

Bioventix's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=12.624/( ( (17.455 - 1.78) + (17.45 - 2.668) )/ 2 )
=12.624/( ( 15.675 + 14.782 )/ 2 )
=12.624/15.2285
=82.90 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 82.90% mean?
Bioventix (BVNXF) has a ROCE % of 82.90% as of Dec. 2025.
Is Bioventix's ROCE % too high?
Bioventix's current ROCE % is 82.90%. Overall, Bioventix has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Bioventix's ROCE % compare to VRTX and REGN?
Bioventix's ROCE % of 82.90% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Bioventix's current ROCE % is 82.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioventix stock overvalued right now?
Bioventix (BVNXF) has a current ROCE % of 82.90%. The stock's GF Value™ is $32.94, compared to a current price of $14.71 — trading 55.3% below its estimated fair value. The current ROCE % is 82.90%. Bioventix's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bioventix (BVNXF), the current ROCE % is 82.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioventix (BVNXF) Overvalued in 2026?

Based on GuruFocus' analysis, Bioventix stock appears to be undervalued. The current stock price of $14.71 is trading 55.3% below its estimated GF Value™ of $32.94.

Key valuation signals for BVNXF:

  • ROCE %: 82.90%
  • GF Value™: $32.94 vs. price of $14.71 (55.3% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the BVNXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioventix Business Description

Other Exchanges BVXP:UK51B:Germany
Address 27-28 Eastcastle Street, London, GBR, W1W 8DH
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.
62GF Score

Get the complete analysis for BVNXF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.71
Price
$32.94
GF Value